ATOS
USDAtossa Therapeutics Inc. Common Stock
$0.756+0.006 (0.827%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$0.750
High
$0.764
Low
$0.726
Volume
0.02M
Company Fundamentals
Market Cap
97.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.63M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.55Current $0.756High $1.81
Related News
GlobeNewswire
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio
SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today
View more
Analyst Upgrades
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.25
Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7 to $7.25.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.